Angiotensin-converting enzyme inhibitors reduce community-acquired pneumonia hospitalization and mortality.
Pharmacotherapy(2022)
摘要
ACEi use in patients at risk of pneumonia without neurological swallowing disorders is associated with reduction in hospitalization and lowering of short- and long-term mortality. Given the high incidence of morbidity and mortality associated with pneumonia, and the susceptibility in older populations with underlying cardiovascular or renal disease or social dependencies, our data support the prescribing of ACEi in these populations to reduce pneumonia hospitalization risk as well as short- and long-term mortality.
更多查看译文
关键词
angiotensin-converting enzyme inhibitors,pharmacology,pneumonia
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要